With cutting-edge automation, the facility can produce mRNA material for up to 100,000 doses of a COVID-19 vaccine daily, ...
Stocktwits on MSN12h
Moderna Stock Slips On Report Of CEO Relinquishing Sales Chief Role: Retail Mood DimsShares of Moderna, Inc. ($MRNA), among the frontrunners in mRNA vaccine technology, fell on Tuesday, bucking the broader market strength. The weakness came after Bloomberg reported, citing a person ...
Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback